Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats

Elizabeth A. Fucich, Denisse Paredes, Madeleine O. Saunders, David A. Morilak

Research output: Contribution to journalArticle

  • 1 Citations

Abstract

Poor response and high relapse rates remain problematic in the treatment of stress-related psychiatric disorders such as depression and post-traumatic stress disorder. Although mechanisms of pharmacotherapies are intensely studied, little is known about mechanisms of behavioral therapy that could inform improved treatments. We have previously demonstrated the therapeutic effects of extinction learning as a behavioral intervention modeling exposure therapy in rats. In the present study, we tested the hypothesis that activity in the ventral medial prefrontal cortex (vmPFC) during extinction is necessary for its therapeutic effects. The inhibitory Gi-coupled designer receptor exclusively activated by designer drug CaMKIIα-hM4Di was expressed invmPFCbefore administering chronic unpredictable stress (CUS).vmPFCprojection neurons were then inhibited during extinction treatment by administering clozapine-N-oxide. Coping behavior and cognitive flexibility were assessed 24 h later on the shock-probe defensive burying test and attentional set-shifting test, respectively. Replicating previous results, extinction reversed the CUS-induced deficits in coping behavior and cognitive flexibility. Inhibiting vmPFC during extinction blocked these therapeutic effects. Further, increasing vmPFC activity with the excitatory Gq-coupled designer receptor exclusively activated by designer drug hM3Dq24 h before testing was sufficient to reverse the CUS-induced deficits. CUS reducedmPFCresponsivity, assessed by measuring afferentevoked field potentials in the mPFC, and this reduction was reversed by extinction treatment 24 h before testing. These results demonstrate the necessity of vmPFC activity in the therapeutic effects of extinction as a model of exposure therapy, and suggest that increased vmPFC activity induced by extinction is sufficient to produce lasting plastic changes that underlie its beneficial effects.

LanguageEnglish (US)
Pages1408-1417
Number of pages10
JournalJournal of Neuroscience
Volume38
Issue number6
DOIs
StatePublished - Feb 7 2018

Fingerprint

Therapeutic Uses
Prefrontal Cortex
Designer Drugs
Implosive Therapy
Psychological Adaptation
Therapeutics
Psychological Extinction
Post-Traumatic Stress Disorders
Psychiatry
Shock
Learning
Depression
Neurons
Recurrence
Drug Therapy

Keywords

  • Behavioral therapy
  • Cognitive flexibility
  • Coping behavior
  • Extinction
  • Medial prefrontal cortex
  • Stress

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats. / Fucich, Elizabeth A.; Paredes, Denisse; Saunders, Madeleine O.; Morilak, David A.

In: Journal of Neuroscience, Vol. 38, No. 6, 07.02.2018, p. 1408-1417.

Research output: Contribution to journalArticle

Fucich, Elizabeth A. ; Paredes, Denisse ; Saunders, Madeleine O. ; Morilak, David A. / Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats. In: Journal of Neuroscience. 2018 ; Vol. 38, No. 6. pp. 1408-1417.
@article{0ffbcaf267dd4b9f8825eeb0eda6b1ee,
title = "Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats",
abstract = "Poor response and high relapse rates remain problematic in the treatment of stress-related psychiatric disorders such as depression and post-traumatic stress disorder. Although mechanisms of pharmacotherapies are intensely studied, little is known about mechanisms of behavioral therapy that could inform improved treatments. We have previously demonstrated the therapeutic effects of extinction learning as a behavioral intervention modeling exposure therapy in rats. In the present study, we tested the hypothesis that activity in the ventral medial prefrontal cortex (vmPFC) during extinction is necessary for its therapeutic effects. The inhibitory Gi-coupled designer receptor exclusively activated by designer drug CaMKIIα-hM4Di was expressed invmPFCbefore administering chronic unpredictable stress (CUS).vmPFCprojection neurons were then inhibited during extinction treatment by administering clozapine-N-oxide. Coping behavior and cognitive flexibility were assessed 24 h later on the shock-probe defensive burying test and attentional set-shifting test, respectively. Replicating previous results, extinction reversed the CUS-induced deficits in coping behavior and cognitive flexibility. Inhibiting vmPFC during extinction blocked these therapeutic effects. Further, increasing vmPFC activity with the excitatory Gq-coupled designer receptor exclusively activated by designer drug hM3Dq24 h before testing was sufficient to reverse the CUS-induced deficits. CUS reducedmPFCresponsivity, assessed by measuring afferentevoked field potentials in the mPFC, and this reduction was reversed by extinction treatment 24 h before testing. These results demonstrate the necessity of vmPFC activity in the therapeutic effects of extinction as a model of exposure therapy, and suggest that increased vmPFC activity induced by extinction is sufficient to produce lasting plastic changes that underlie its beneficial effects.",
keywords = "Behavioral therapy, Cognitive flexibility, Coping behavior, Extinction, Medial prefrontal cortex, Stress",
author = "Fucich, {Elizabeth A.} and Denisse Paredes and Saunders, {Madeleine O.} and Morilak, {David A.}",
year = "2018",
month = "2",
day = "7",
doi = "10.1523/JNEUROSCI.0635-17.2017",
language = "English (US)",
volume = "38",
pages = "1408--1417",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "6",

}

TY - JOUR

T1 - Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats

AU - Fucich, Elizabeth A.

AU - Paredes, Denisse

AU - Saunders, Madeleine O.

AU - Morilak, David A.

PY - 2018/2/7

Y1 - 2018/2/7

N2 - Poor response and high relapse rates remain problematic in the treatment of stress-related psychiatric disorders such as depression and post-traumatic stress disorder. Although mechanisms of pharmacotherapies are intensely studied, little is known about mechanisms of behavioral therapy that could inform improved treatments. We have previously demonstrated the therapeutic effects of extinction learning as a behavioral intervention modeling exposure therapy in rats. In the present study, we tested the hypothesis that activity in the ventral medial prefrontal cortex (vmPFC) during extinction is necessary for its therapeutic effects. The inhibitory Gi-coupled designer receptor exclusively activated by designer drug CaMKIIα-hM4Di was expressed invmPFCbefore administering chronic unpredictable stress (CUS).vmPFCprojection neurons were then inhibited during extinction treatment by administering clozapine-N-oxide. Coping behavior and cognitive flexibility were assessed 24 h later on the shock-probe defensive burying test and attentional set-shifting test, respectively. Replicating previous results, extinction reversed the CUS-induced deficits in coping behavior and cognitive flexibility. Inhibiting vmPFC during extinction blocked these therapeutic effects. Further, increasing vmPFC activity with the excitatory Gq-coupled designer receptor exclusively activated by designer drug hM3Dq24 h before testing was sufficient to reverse the CUS-induced deficits. CUS reducedmPFCresponsivity, assessed by measuring afferentevoked field potentials in the mPFC, and this reduction was reversed by extinction treatment 24 h before testing. These results demonstrate the necessity of vmPFC activity in the therapeutic effects of extinction as a model of exposure therapy, and suggest that increased vmPFC activity induced by extinction is sufficient to produce lasting plastic changes that underlie its beneficial effects.

AB - Poor response and high relapse rates remain problematic in the treatment of stress-related psychiatric disorders such as depression and post-traumatic stress disorder. Although mechanisms of pharmacotherapies are intensely studied, little is known about mechanisms of behavioral therapy that could inform improved treatments. We have previously demonstrated the therapeutic effects of extinction learning as a behavioral intervention modeling exposure therapy in rats. In the present study, we tested the hypothesis that activity in the ventral medial prefrontal cortex (vmPFC) during extinction is necessary for its therapeutic effects. The inhibitory Gi-coupled designer receptor exclusively activated by designer drug CaMKIIα-hM4Di was expressed invmPFCbefore administering chronic unpredictable stress (CUS).vmPFCprojection neurons were then inhibited during extinction treatment by administering clozapine-N-oxide. Coping behavior and cognitive flexibility were assessed 24 h later on the shock-probe defensive burying test and attentional set-shifting test, respectively. Replicating previous results, extinction reversed the CUS-induced deficits in coping behavior and cognitive flexibility. Inhibiting vmPFC during extinction blocked these therapeutic effects. Further, increasing vmPFC activity with the excitatory Gq-coupled designer receptor exclusively activated by designer drug hM3Dq24 h before testing was sufficient to reverse the CUS-induced deficits. CUS reducedmPFCresponsivity, assessed by measuring afferentevoked field potentials in the mPFC, and this reduction was reversed by extinction treatment 24 h before testing. These results demonstrate the necessity of vmPFC activity in the therapeutic effects of extinction as a model of exposure therapy, and suggest that increased vmPFC activity induced by extinction is sufficient to produce lasting plastic changes that underlie its beneficial effects.

KW - Behavioral therapy

KW - Cognitive flexibility

KW - Coping behavior

KW - Extinction

KW - Medial prefrontal cortex

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=85041750842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041750842&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.0635-17.2017

DO - 10.1523/JNEUROSCI.0635-17.2017

M3 - Article

VL - 38

SP - 1408

EP - 1417

JO - Journal of Neuroscience

T2 - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 6

ER -